Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Sparton Resources turns to Q2 loss of CAD 2,630; revenue rises to CAD 125,394 in Q2 FY26

Sparton Resources turns to Q2 loss of CAD 2,630; revenue rises to CAD 125,394 in Q2 FY26

ReutersReuters2026/08/27 16:06
  • Sparton Resources posted a net loss of CAD 147,157 for the six months ended June 30, 2026, versus net income CAD 88,334.
  • Revenue turned to CAD 125,394 from no revenue, reflecting contract drilling activity; gross profit was CAD 10,412.
  • Cash fell to CAD 869 at June 30, 2026 from CAD 284,485 at Dec. 31, 2025; working capital deficit widened to CAD 357,652.
  • Long-term investment in VRB Energy was valued at CAD 1.66 million at June 30, 2026, up from CAD 1.6 million at Dec. 31, 2025.
  • Sparton signed a binding letter of intent June 17, 2026 for a three-year option on the past-producing Morrison Silver Mine in Ontario.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sparton Resources Inc. published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)